Apyx Medical
APYX
61 hedge funds and large institutions have $83.9M invested in Apyx Medical in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.29% less ownership
Funds ownership: 52.36% → 52.07% (-0.29%)
2% less funds holding
Funds holding: 62 → 61 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
16% less capital invested
Capital invested by funds: $99.4M → $83.9M (-$15.5M)
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$1.01M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$385K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$267K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$188K |
| 5 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QI
QS Investors
New York
|
-$886K |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$800K |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$391K |
| 4 |
JP Morgan Chase
New York
|
-$242K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$236K |
APYX Hedge Fund Activity: Q3 2020 in Review
61 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2020, worth a combined $83.9M — down 16% from $99.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of APYX and 7 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 15 added.
The largest buyer was Royce & Associates, adding an estimated $1.01M. The largest seller was QS Investors, cutting an estimated $886K.
- 61 institutional investors held Apyx Medical (APYX) as of Q3 2020, down from 62 in Q2 2020.
- Funds reported $83.9M of Apyx Medical stock for Q3 2020, down 16% quarter-over-quarter.
- 7 funds opened new Apyx Medical positions in Q3 2020 and 8 closed out, a net change of -1 holder.
- The largest Apyx Medical buyer in Q3 2020 was Royce & Associates, an estimated $1.01M added.
- The largest Apyx Medical seller in Q3 2020 was QS Investors, an estimated $886K sold.
Based on aggregated 13F filings for Q3 2020.